Standing Ovation's $34.2M Series B: Government Funds Beat VCs
Standing Ovation, a French precision fermentation company, closed a $34.2M Series B led by government-backed funds instead of traditional venture capital, signaling a structural shift in deep-tech biotech funding.
April 3, 2026
Ares Management's $5.4B Real Estate Fund Close Signals LP Rotation
Ares Management's $5.4B real estate fund close marks the largest PE-backed real estate vehicle in history, signaling LP capital rotation away from tech concentration toward alternative investments.
April 3, 2026
Retail Real Estate Fund Institutional Capital 2026: Nuveen's $330M Close
Nuveen's U.S. Cities Retail Fund closes at $330M with Australian superannuation funds, led by Rest's $250M commitment. Institutional capital bets on grocery-anchored retail resilience.
April 3, 2026
Series B Enterprise AI: Why Privacy Infrastructure Wins
Institutional investors are backing B2B privacy infrastructure over consumer AI chatbots. Alcatraz's $50M Series B shows why enterprise authentication solving compliance problems attracts serious capital.
April 3, 2026
EdTech: The $2.4B Valley & How Angels Are Winning in 2025
The 2024 EdTech funding crisis hit $2.4B—lowest in a decade. But 2025 is different. Here's where angels are actually finding winners.
April 3, 2026
Healthcare & Biotech: The $25.1B Market & Mega-Rounds in 2025
The US healthcare market is expanding to $5.15T in 2026. Biotech VC hit $25.1B in 2024. Here's where angels find the biggest exits.
April 3, 2026
The Top 20 Most Active Angel Groups in America — 2025 Rankings by Deals & Capital
Discover which angel groups closed the most deals and deployed the most capital in 2025. Rankings, investment metrics, and regional insights.
April 3, 2026
Fintech: The $28B Market Rebounding in 2025-2026
Fintech funding hit $28B in 2024 and is rebounding with 27% growth projected for 2025. Learn why angels should care about regulatory tailwinds, mega-rounds, and consolidation.
April 3, 2026
Founders Are Giving Away Too Much Too Fast: The Complete Guide to Seed Round Equity Dilution
The complete guide to seed round equity dilution. Learn market standards, negotiate better terms, and avoid the $10M mistake founders make with equity.
April 3, 2026
Stop Wasting Time on Generic Investor Lists
Build a professional investor target list in 30 days. Stop wasting time on generic lists. Smart founders target 50 investors, not 500.
April 3, 2026
Why Founders Skip Angels (And Regret It)
Most founders raise from VCs first. The best ones start with angels. Here's why angel investors matter more than you think.
April 3, 2026
CLO Securitization 2026: Why Accredited Investors Are Rotating Into Collateralized Loan Obligations
CLO securitization is delivering superior risk-adjusted returns for accredited investors seeking yield without concentration risk. Canyon Partners' $500M CLO 2026-1 exemplifies institutional demand for structured credit in a saturated direct lending market.
April 3, 2026